BrP-LPA


SMILES CCCCCCCCCCCCCCCC(=O)OC[C@H](CC(P(=O)(O)O)Br)O
InChIKey HLVKVWDSLLFMSX-OYKVQYDMSA-N

Chemical properties

Hydrogen bond acceptors 4
Hydrogen bond donors 3
Rotatable bonds 19
Molecular weight (Da) 486.2

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Sankey plot

Compound is not listed as a drug.


Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
LPA1 LPAR1 Human Lysophospholipid (LPA) A pKi 6.09 6.09 6.09 Guide to Pharmacology
LPA2 LPAR2 Mouse Lysophospholipid (LPA) A pKi 6.61 6.61 6.61 Guide to Pharmacology
LPA2 LPAR2 Human Lysophospholipid (LPA) A pKi 6.77 6.77 6.77 ChEMBL
LPA3 LPAR3 Human Lysophospholipid (LPA) A pKi 6.77 6.77 6.77 ChEMBL
LPA1 LPAR1 Human Lysophospholipid (LPA) A pKi 6.77 6.77 6.77 ChEMBL
LPA4 LPAR4 Human Lysophospholipid (LPA) A pKi 6.77 6.77 6.77 ChEMBL
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
LPA1 LPAR1 Human Lysophospholipid (LPA) A pIC50 5.34 5.34 5.34 Guide to Pharmacology
LPA2 LPAR2 Mouse Lysophospholipid (LPA) A pIC50 6.33 6.33 6.33 Guide to Pharmacology